Pietro Mittica
University of Siena
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pietro Mittica.
Clinical and Experimental Ophthalmology | 2017
Antonio Maria Fea; Iqbal Ike K. Ahmed; Carlo Lavia; Pietro Mittica; Giulia Consolandi; Ilaria Motolese; Giulia Pignata; Eduardo Motolese; Teresa Rolle; Paolo Frezzotti
To compare the reduction of intraocular pressure (IOP) and glaucoma medications following selective laser trabeculoplasty (SLT) versus stand‐alone placement of the Hydrus microstent, a microinvasive glaucoma surgery device.
Acta Ophthalmologica | 2014
Paolo Frezzotti; Paolo Fogagnolo; Gentiana Haka; Ilaria Motolese; Michele Iester; Simone Alex Bagaglia; Pietro Mittica; Cristina Menicacci; Luca Rossetti; Eduardo Motolese
To evaluate the effects at 1 year of preservative‐free timolol gel and preserved timolol eye drops on conjunctiva and tear parameters.
British Journal of Ophthalmology | 2011
Paolo Frezzotti; Chiara Pescucci; Filomena Tiziana Papa; Michele Iester; V. Mittica; Ilaria Motolese; Sabrina Peruzzi; Rosangela Artuso; Ilaria Longo; Maria Antonietta Mencarelli; Pietro Mittica; Eduardo Motolese; Alessandra Renieri
Background/aims To assess the involvement of WDR36 sequence variance in primary open-angle glaucoma (POAG) in Italian patients. Methods A cohort of 34 Italian families affected by POAG was analysed by denaturing high-performance liquid chromatography for mutation in the WDR36 gene. Among the 34 families enrolled, 25 were affected by high-tension glaucoma (HTG), four by juvenile open-angle glaucoma and one by normal tension glaucoma. In addition, four families presented both juvenile open-angle glaucoma and HTG-POAG patients within the same pedigree. Results Four previously identified intronic polymorphisms (IVS5+30C→T; IVS12+90 G→T; IVS13+89G→A; IVS16-30A→G) and a novel one (IVS21-75G→A) have been identified. In addition, one proband was found to carry the p.D658G mutation reported as the more recurrent disease-causing allele. Conclusions The findings suggest that WDR36 sequence variance is only a rare cause of glaucoma in Italian families. Clearly, investigation of additional families with extensive studies is needed to clarify the role of WDR36 in the pathophysiology of glaucoma.
PLOS ONE | 2015
Luca Rossetti; Maurizio Digiuni; Montesano Giovanni; Marco Centofanti; Antonio Maria Fea; Michele Iester; Paolo Frezzotti; Michele Figus; Antonio Ferreras; Francesco Oddone; Lucia Tanga; Teresa Rolle; Valentina Battaglino; Chiara Posarelli; Ilaria Motolese; Pietro Mittica; Simone Alex Bagaglia; Cristina Menicacci; Stefano De Cillà; Alessandro Autelitano; Paolo Fogagnolo
Purpose To evaluate frequency, conversion rate, and risk factors for blindness in glaucoma patients treated in European Universities. Methods This multicenter retrospective study included 2402 consecutive patients with glaucoma in at least one eye. Medical charts were inspected and patients were divided into those blind and the remainder (‘controls’). Blindness was defined as visual acuity≤0.05 and/or visual field loss to less than 10°. Results Unilateral and bilateral blindness were respectively 11.0% and 1.6% at the beginning, and 15.5% and 3.6% at the end of the observation period (7.5±5.5 years, range:1–25 years); conversion to blindness (at least unilateral) was 1.1%/year. 134 eyes (97 patients) developed blindness by POAG during the study. At the first access to study centre, they had mean deviation (MD) of -17.1±8.3 dB and treated intraocular pressure (IOP) of 17.1±6.6 mmHg. During follow-up the IOP decreased by 14% in these eyes but MD deteriorated by 1.1±3.5 dB/year, which was 5-fold higher than controls (0.2±1.6 dB/year). In a multivariate model, the best predictors for blindness by glaucoma were initial MD (p<0.001), initial IOP (p<0.001), older age at the beginning of follow-up (p<0.001), whereas final IOP was found to be protective (p<0.05). Conclusions In this series of patients, blindness occurred in about 20%. Blindness by glaucoma had 2 characteristics: late diagnosis and/or late referral, and progression of the disease despite in most cases IOP was within the range of normality and target IOP was achieved; it could be predicted by high initial MD, high initial IOP, and old age.
PLOS ONE | 2016
Luca Rossetti; Maurizio Digiuni; Giovanni Montesano; Marco Centofanti; Antonio Maria Fea; Michele Iester; Paolo Frezzotti; Michele Figus; Antonio Ferreras; Francesco Oddone; Lucia Tanga; Teresa Rolle; Valentina Battaglino; Chiara Posarelli; Ilaria Motolese; Pietro Mittica; Simone Alex Bagaglia; Cristina Menicacci; Stefano De Cillà; Alessandro Autelitano; Paolo Fogagnolo
BMC Ophthalmology | 2016
Paolo Frezzotti; Cristina Menicacci; Simone Alex Bagaglia; Pietro Mittica; Francesca Toto; Ilaria Motolese
OTTICA FISIOPATOLOGICA | 2013
P Esposti; Rosario Denaro; Paolo Frezzotti; E Polito; Pietro Mittica; Maria Cristina Sparagna; G. Esposti; Mario Fruschelli; Ilaria Motolese
OTTICA FISIOPATOLOGICA | 2013
Paolo Frezzotti; Alessandra Rufa; Ilaria Motolese; Michele Iester; Gian Nicola Gallus; Elena Cardaioli; Simone Alex Bagaglia; Pietro Mittica; Cristina Menicacci; D. Turco; Antonio Federico; Eduardo Motolese
MINERVA OFTALMOLOGICA | 2012
Paolo Frezzotti; Pietro Mittica; Simone Alex Bagaglia; Ilaria Motolese; Enicacci C. M; Eduardo Motolese; André Reis; Francesca Pasutto
Investigative Ophthalmology & Visual Science | 2012
Paolo Fogagnolo; Paolo Frezzotti; Pietro Mittica; Maurizio Digiuni; Ruggiero Paderni; Elena Vallenzasca; Luca Rossetti